Failure to Report Harms and Adverse Events in Clinical Trials: Why Does the Problem Continue?

Canadian Journal of Anaesthesia - United States
doi 10.1007/s12630-012-9777-6
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Inappropriate Grading of Adverse Events in Cancer Clinical Trials—Reply

JAMA Oncology
Cancer ResearchOncology
2019English

A Review of Methods for Monitoring Adverse Events in Pediatric Psychopharmacology Clinical Trials

Drug Safety
ToxicologyPharmacology
2018English

Pcn368 - Concordance Between Patients and Clinicians’ Reporting of Symptomatic Adverse Events in Cancer Clinical Trials: A Systematic Review

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Why Argentine Private Universities Continue to Lag

International Higher Education
2015English

Clinical Translational Failure in Neuroprotective Agents: The Steps From Animal Experiments to Clinical Trials

Medical science monitor basic research
Medicine
2013English

Using Electronic Medical Record Data to Report Laboratory Adverse Events

British Journal of Haematology
Hematology
2017English

Screening Colonoscopy Adverse Events in Aging Adults: Does Frailty Matter?

Journal of Geriatric Medicine and Gerontology
2018English

Delayed Adverse Events in Phase I Trials of Molecularly Targeted and Cytotoxic Agents

Oncotarget
Oncology
2018English

Disclosing Clinical Adverse Events to Patients: Can Practice Inform Policy?

Health Expectations
EnvironmentalPublic HealthOccupational Health
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy